| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| BIOREGENX, INC. | CEO, Interim CFO, Director, 10%+ Owner | Common | 197,864,944 | 08 Mar 2024 | Trustee of Wilshire Holdings Trust | ||
| BIOREGENX, INC. | CEO, Interim CFO, Director, 10%+ Owner | Common | 20,674,000 | 08 Mar 2024 | Direct | ||
| BIOREGENX, INC. | CEO, Interim CFO, Director, 10%+ Owner | Series A Preferred | 1,008 | 08 Mar 2024 | Trustee of Wilshire Holdings Trust | ||
| BIOREGENX, INC. | CEO, Interim CFO, Director, 10%+ Owner | Series A Preferred | 112 | 08 Mar 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| BRGX | BIOREGENX, INC. | 08 Mar 2024 | 0 | $0 | 3 | CEO, Interim CFO, Director, 10%+ Owner | 22 May 2024, 13:12 |